Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression.

Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression. Abstract Text:

    teruyasu ohnoTeruyasu Ohno,michael pelzerMichael Pelzer,mikko larsenMikko Larsen,patricia f friedrichPatricia F Friedrich,allen t bishopAllen T Bishop,teruyasu ohnoTeruyasu Ohno,michael pelzerMichael Pelzer,mikko larsenMikko Larsen,patricia f friedrichPatricia F Friedrich,allen t bishopAllen T Bishop,

    A novel method of living bone allotransplantation combining microvascular repair of the nutrient circulation, implantation of host-derived arteriovenous (AV) bundles, and short-term immunosuppression is described. We hypothesized that neoangiogenesis from the implanted vessels would maintain graft viability and circulation after withdrawal of FK506 (Tacrolimus) immunosuppression. Vascularized femoral transplantation was performed between DA and PVG rats. In addition to microsurgical pedicle anastomoses, a saphenous AV bundle from the recipient animal was implanted in the medullary space. Ninety-seven rats were randomly allocated to groups differing in immunosuppression and AV bundle patency. Implanted vessels significantly improved capillary density and bone blood flow in nonimmunosuppressed and immmunosuppressed groups, respectively. A lower incidence of spontaneous AV bundle thrombosis was found with Tacrolimus treatment. More viable osteocytes were seen at 4 weeks when the AV bundle was patent. Further investigations may confirm host-derived neoangiogenesis as an alternative to tolerance induction or immunosuppression in bone allotransplantation. (c) 2007 Wiley-Liss, Inc. Microsurgery, 2007.

    Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression. Publishing Authors By Initials

    t ohnoT Ohno,m pelzerM Pelzer,m larsenM Larsen,pf friedrichPF Friedrich,at bishopAT Bishop,t ohnoT Ohno,m pelzerM Pelzer,m larsenM Larsen,pf friedrichPF Friedrich,at bishopAT Bishop,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Microsurgery

    VOLUME: 27

    Page Numbers: 657-63

    Journal Abbreviation:

    ISSN: 0738-1085

    DAY: 5

    MONTH: 11

    YEAR: 2007

    Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8309230

    Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression.

    AFFILIATION: Department of Orthopedic Surgery, Microvascular Research Laboratory, Mayo Clinic, Rochester, MN.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Microsurgery

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News